priorix-tetra 0.5 ml powder for solution for injection (s.c./1.m.)
glaxosmithkline philippines, inc.; distributor: glaxosmithkline philippines, inc. - measles, mumps, rubella and varicella vaccine (live, attenuated) - powder for solution for injection (s.c./1.m.) - 0.5 ml
avodart 500 mcg softgel capsule
glaxosmithkline philippines, inc.; distributor: glaxosmithkline philippines, inc. - dutasteride - softgel capsule - 500 mcg
lamictal 5 mg dispersible/chewable tablet
glaxosmithkline philippines, inc.; distributor: glaxosmithkline philippines, inc. - lamotrigine - dispersible/chewable tablet - 5 mg
synflorix 0.5ml suspension for injection
glaxosmithkline philippines, inc.; distributor: glaxosmithkline philippines, inc. - pneumococcal polysaccharide and non-typeable haemophilus influenzae (nthi) protein d conjugate vaccine, adsorbed - suspension for injection - 0.5ml
synflorix suspension for injection (im)
glaxosmithkline philippines, inc.; distributor: glaxosmithkline philippines, inc. - pneumococcal polysaccharide conjugate vaccine (adsorbed) - suspension for injection (im) - each 0.5 ml dose contains: 1 mcg of polysaccharide for serotypes 1 1,2, 5 1,2, 6b 1,2, 7f1.2, 9v 1,2, 14 1,2 and 23f 1,2 and 3 mcg of serotypes 4 1,2, 18c 1,3, and 19f 1,4 'adsorbed on aluminium phosphate 500 mcg a 13+ 2conjugate to protein d (derived from non-typeable haemophilus influenzae) carrier protein eq. to 9-16 mcg 3conjugate to tetanus toxoid carrier protein eq. to 5-10 mcg 4conjugate to diphtheria toxoid carrier protein e.q. to 3-6 mcg
synflorix 0.5ml suspension for injection
glaxosmithkline philippines, inc.; distributor: glaxosmithkline philippines, inc. - pneumococcal polysaccharide and non-typeable haemophilus influenzae (nthi) protein d conjugate vaccine, adsorbed - suspension for injection - 0.5ml
benlysta powder for solution for injection (iv infusion)
glaxosmithkline philippines inc.; distributor: glaxosmithkline philippines inc. - belimumab - powder for solution for injection (iv infusion) - 120 mg vial each vial contains a sufficient amount of belimumab to deliver 120 mg in 1.5 ml when reconstituted as recommended with sterile water for injections. after reconstitution, each ml of solution contains 80 mg belimumab. 400 mg vial each vial contains a sufficient amount of belimumab to deliver 400 mg in 5.0 ml when reconstituted as recommended with sterile water for injections. after reconstitution, each ml of solution contains 80 mg belimumab.
arexvy 120 mcg powder for suspension for injection (im)
glaxosmithkline philippines, inc.; distributor: glaxosmithkline philippines, inc. - respiratory syncytial virus vaccine (recombinant, adjuvanted) - powder for suspension for injection (im) - 120 mcg
malanil 250 mg/ 100 mg film-coated tablet
glaxosmithkline philippines, inc. - atovaquone , proguanil hydrochloride - film-coated tablet - 250 mg/ 100 mg
zovirax 250 mg powder for intravenous (iv) infusion
glaxosmithkline philippines, inc. - acyclovir - powder for intravenous (iv) infusion - 250 mg